NCT03101358
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations:
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Phase 1|Phase 2
Drug Category: Chemotherapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Skin
Additional Notes: 
Exclusions: 
https://ClinicalTrials.gov/show/NCT03101358